Christian von Plessen

Summary

Affiliation: Haukeland University Hospital
Country: Norway

Publications

  1. ncbi [Lung cancer--of more current interest than before]
    Roy M Bremnes
    Kreftavdelingen, Universitetssykehuset Nord-Norge
    Tidsskr Nor Laegeforen 126:1940. 2006
  2. ncbi Improving the quality of palliative care for ambulatory patients with lung cancer
    Christian von Plessen
    Department of Thoracic Medicine, Haukeland University Hospital, N 5021 Bergen, Norway
    BMJ 330:1309-13. 2005
  3. ncbi Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer
    C von Plessen
    Department of Thoracic Medicine, Haukeland University Hospital and Institute of Medicine, University of Bergen, N 5018 Bergen, Norway
    Br J Cancer 95:966-73. 2006
  4. ncbi Effectiveness of third-generation chemotherapy on the survival of patients with advanced non-small cell lung cancer in Norway: a national study
    C von Plessen
    Department of Thoracic Medicine, Haukeland University Hospital, N 5021 Bergen, Norway
    Thorax 63:866-71. 2008

Detail Information

Publications4

  1. ncbi [Lung cancer--of more current interest than before]
    Roy M Bremnes
    Kreftavdelingen, Universitetssykehuset Nord-Norge
    Tidsskr Nor Laegeforen 126:1940. 2006
  2. ncbi Improving the quality of palliative care for ambulatory patients with lung cancer
    Christian von Plessen
    Department of Thoracic Medicine, Haukeland University Hospital, N 5021 Bergen, Norway
    BMJ 330:1309-13. 2005
    ..At the same time, members of staff often waste considerable time and energy in organisational aspects of care that could be better used in direct interaction with patients...
  3. ncbi Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer
    C von Plessen
    Department of Thoracic Medicine, Haukeland University Hospital and Institute of Medicine, University of Bergen, N 5018 Bergen, Norway
    Br J Cancer 95:966-73. 2006
    ..21, HR 0.86, 95% CI 0.68-1.08). In conclusion, palliative chemotherapy with carboplatin and vinorelbine beyond three courses conveys no survival or consistent QoL benefits in advanced NSCLC...
  4. ncbi Effectiveness of third-generation chemotherapy on the survival of patients with advanced non-small cell lung cancer in Norway: a national study
    C von Plessen
    Department of Thoracic Medicine, Haukeland University Hospital, N 5021 Bergen, Norway
    Thorax 63:866-71. 2008
    ....